Park West Asset Management’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
Park West Asset Management's TLSI Position: Q3 2021 in Review
Park West Asset Management sold out of TriSalus Life Sciences (TLSI) in Q3 2021, closing a stake of 1,250,000 shares — an estimated $12.1M sold.
Park West Asset Management first reported a position in TLSI in Q1 2021 and held it in 2 quarters. The position peaked at $12.1M in Q2 2021. 66 funds tracked by Wall St. Rank hold TLSI as of Q3 2021.
- Park West Asset Management reported no remaining TriSalus Life Sciences position as of Q3 2021 after selling out during the quarter.
- Park West Asset Management sold 1,250,000 TriSalus Life Sciences shares in Q3 2021, an estimated $12.1M.
- Park West Asset Management first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 2 quarters.
- Park West Asset Management's TriSalus Life Sciences position peaked at $12.1M in Q2 2021.
- 66 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2021.
Based on Park West Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.